Logo image of OBE.CA

OBSIDIAN ENERGY LTD (OBE.CA) Stock Fundamental Analysis

Canada - TSX:OBE - CA6744822033 - Common Stock

8.7 CAD
-0.04 (-0.46%)
Last: 9/18/2025, 7:00:00 PM
Fundamental Rating

3

Overall OBE gets a fundamental rating of 3 out of 10. We evaluated OBE against 216 industry peers in the Oil, Gas & Consumable Fuels industry. OBE has a medium profitability rating, but doesn't score so well on its financial health evaluation. OBE is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

OBE had negative earnings in the past year.
In the past year OBE had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: OBE reported negative net income in multiple years.
OBE had a positive operating cash flow in each of the past 5 years.
OBE.CA Yearly Net Income VS EBIT VS OCF VS FCFOBE.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1B -2B

1.2 Ratios

With a Return On Assets value of -11.86%, OBE is not doing good in the industry: 62.96% of the companies in the same industry are doing better.
OBE's Return On Equity of -15.86% is in line compared to the rest of the industry. OBE outperforms 41.20% of its industry peers.
The Return On Invested Capital of OBE (7.74%) is better than 87.04% of its industry peers.
OBE had an Average Return On Invested Capital over the past 3 years of 8.82%. This is in line with the industry average of 6.93%.
Industry RankSector Rank
ROA -11.86%
ROE -15.86%
ROIC 7.74%
ROA(3y)10.66%
ROA(5y)-3.82%
ROE(3y)14.48%
ROE(5y)-28.26%
ROIC(3y)8.82%
ROIC(5y)8.37%
OBE.CA Yearly ROA, ROE, ROICOBE.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150 -200

1.3 Margins

With a decent Operating Margin value of 24.16%, OBE is doing good in the industry, outperforming 75.00% of the companies in the same industry.
OBE's Operating Margin has declined in the last couple of years.
OBE's Gross Margin of 69.68% is amongst the best of the industry. OBE outperforms 89.81% of its industry peers.
OBE's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 24.16%
PM (TTM) N/A
GM 69.68%
OM growth 3Y-12.26%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.26%
GM growth 5Y2.34%
OBE.CA Yearly Profit, Operating, Gross MarginsOBE.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 -200

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), OBE is destroying value.
The number of shares outstanding for OBE has been reduced compared to 1 year ago.
The number of shares outstanding for OBE has been increased compared to 5 years ago.
Compared to 1 year ago, OBE has a worse debt to assets ratio.
OBE.CA Yearly Shares OutstandingOBE.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
OBE.CA Yearly Total Debt VS Total AssetsOBE.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

OBE has an Altman-Z score of 0.88. This is a bad value and indicates that OBE is not financially healthy and even has some risk of bankruptcy.
OBE has a Altman-Z score (0.88) which is in line with its industry peers.
OBE has a debt to FCF ratio of 5.61. This is a neutral value as OBE would need 5.61 years to pay back of all of its debts.
The Debt to FCF ratio of OBE (5.61) is better than 75.93% of its industry peers.
A Debt/Equity ratio of 0.13 indicates that OBE is not too dependend on debt financing.
The Debt to Equity ratio of OBE (0.13) is better than 68.06% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF 5.61
Altman-Z 0.88
ROIC/WACC0.85
WACC9.11%
OBE.CA Yearly LT Debt VS Equity VS FCFOBE.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B

2.3 Liquidity

OBE has a Current Ratio of 0.80. This is a bad value and indicates that OBE is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of OBE (0.80) is comparable to the rest of the industry.
OBE has a Quick Ratio of 0.80. This is a bad value and indicates that OBE is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of OBE (0.80) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 0.8
Quick Ratio 0.8
OBE.CA Yearly Current Assets VS Current LiabilitesOBE.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2

3. Growth

3.1 Past

The earnings per share for OBE have decreased strongly by -310.93% in the last year.
OBE shows a small growth in Revenue. In the last year, the Revenue has grown by 1.85%.
Measured over the past years, OBE shows a quite strong growth in Revenue. The Revenue has been growing by 13.38% on average per year.
EPS 1Y (TTM)-310.93%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-55.11%
Revenue 1Y (TTM)1.85%
Revenue growth 3Y17.6%
Revenue growth 5Y13.38%
Sales Q2Q%-39.34%

3.2 Future

The Earnings Per Share is expected to decrease by -77.09% on average over the next years. This is quite bad
Based on estimates for the next years, OBE will show a very negative growth in Revenue. The Revenue will decrease by -11.43% on average per year.
EPS Next Y-183.51%
EPS Next 2Y-77.09%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-20.99%
Revenue Next 2Y-11.43%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
OBE.CA Yearly Revenue VS EstimatesOBE.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B 2B
OBE.CA Yearly EPS VS EstimatesOBE.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -50 -100 -150

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for OBE. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for OBE. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OBE.CA Price Earnings VS Forward Price EarningsOBE.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

95.83% of the companies in the same industry are more expensive than OBE, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, OBE is valued a bit cheaper than 68.06% of the companies in the same industry.
Industry RankSector Rank
P/FCF 14.39
EV/EBITDA 2.07
OBE.CA Per share dataOBE.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 15 20

4.3 Compensation for Growth

OBE's earnings are expected to decrease with -77.09% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-77.09%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for OBE!.
Industry RankSector Rank
Dividend Yield N/A

OBSIDIAN ENERGY LTD

TSX:OBE (9/18/2025, 7:00:00 PM)

8.7

-0.04 (-0.46%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)07-30 2025-07-30
Earnings (Next)10-30 2025-10-30
Inst Owners27.43%
Inst Owner ChangeN/A
Ins Owners3.72%
Ins Owner ChangeN/A
Market Cap582.81M
Analysts72.5
Price Target9.95 (14.37%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)2.63%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-1471.43%
EPS NY rev (3m)-1471.43%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)3.8%
Revenue NY rev (3m)-8.18%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.83
P/FCF 14.39
P/OCF 1.55
P/B 0.42
P/tB 0.42
EV/EBITDA 2.07
EPS(TTM)-2.74
EYN/A
EPS(NY)-8.58
Fwd EYN/A
FCF(TTM)0.6
FCFY6.95%
OCF(TTM)5.63
OCFY64.72%
SpS10.52
BVpS20.79
TBVpS20.79
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -11.86%
ROE -15.86%
ROCE 10.29%
ROIC 7.74%
ROICexc 7.75%
ROICexgc 7.75%
OM 24.16%
PM (TTM) N/A
GM 69.68%
FCFM 5.75%
ROA(3y)10.66%
ROA(5y)-3.82%
ROE(3y)14.48%
ROE(5y)-28.26%
ROIC(3y)8.82%
ROIC(5y)8.37%
ROICexc(3y)8.83%
ROICexc(5y)8.4%
ROICexgc(3y)8.83%
ROICexgc(5y)8.4%
ROCE(3y)11.73%
ROCE(5y)11.13%
ROICexcg growth 3Y-18.98%
ROICexcg growth 5YN/A
ROICexc growth 3Y-18.98%
ROICexc growth 5YN/A
OM growth 3Y-12.26%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.26%
GM growth 5Y2.34%
F-Score6
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF 5.61
Debt/EBITDA 0.45
Cap/Depr 152.01%
Cap/Sales 47.79%
Interest Coverage 5.54
Cash Conversion 96.3%
Profit Quality N/A
Current Ratio 0.8
Quick Ratio 0.8
Altman-Z 0.88
F-Score6
WACC9.11%
ROIC/WACC0.85
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)47.68%
Cap/Sales(5y)38.88%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-310.93%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-55.11%
EPS Next Y-183.51%
EPS Next 2Y-77.09%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)1.85%
Revenue growth 3Y17.6%
Revenue growth 5Y13.38%
Sales Q2Q%-39.34%
Revenue Next Year-20.99%
Revenue Next 2Y-11.43%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y1.67%
EBIT growth 3Y3.18%
EBIT growth 5YN/A
EBIT Next Year67.46%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-38.17%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-2.68%
OCF growth 3Y22.12%
OCF growth 5Y36.28%